Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer

NCT07673211 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Recurrent Cervical Cancer
Metastatic Cervical Cancer

Interventions

DIAGNOSTIC_TEST: Biospecimen collection (peripheral blood and paraffin tumor tissue)

Sponsor

Zhejiang Cancer Hospital